CEO Mark Locke Sells $5.3M of Genius Sports Stock, Enters Zero-Cost Collar on 4.4M Shares
GENI sits 70% above its 52-week low of $3.825.
Summary
Genius Sports CEO Mark Locke sold $5.3 million of stock and entered a zero-cost collar on 4.4 million shares, hedging downside while capping upside.
Key Events · Ownership and Investor Activity · GENI
-
CEO Sells $5.3M of Stock
Mark Locke sold 800,001 ordinary shares for $5,255,567.72 at $6.54-$6.58 per share between September 15-17, 2026.
-
Zero-Cost Collar on 4.4M Shares
Locke entered a zero-cost collar covering 4,400,000 shares with a $10.20 call and $5.00 put, expiring September 6, 2028. No premium was exchanged.
-
Hedging, Not Liquidation
The collar protects against downside below $5.00 while capping upside above $10.20, indicating a hedging strategy rather than outright bearishness.
-
Post-Transaction Holdings
Locke retains 19,697,767 ordinary shares directly following the transactions.
Analysis · GENI · Trade & Services
CEO Mark Locke sold 800,001 ordinary shares for $5.26 million at $6.54-$6.58 per share over three days, and simultaneously entered a zero-cost collar covering 4.4 million shares with a $10.20 call and $5.00 put expiring September 2028. The collar hedges downside below $5.00 while capping upside above $10.20, suggesting the CEO is protecting value rather than expressing outright bearishness. The sale is notable for a sitting CEO, but the collar structure indicates a hedging strategy rather than a liquidation signal.
How filings like this one have moved
In the 30 days to Sep 30, 2026, 29.6% of the 1609 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.57%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, GENI was trading at $6.49 on NYSE in the Trade & Services sector, with a market capitalization of approximately $1.8B. The 52-week trading range was $3.83 to $13.69. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.